KIM ACE Global Big Pharma ETF Units (497510.KQ) Price

KIM ACE Global Big Pharma ETF Units is offered by ACE, a leading player in the field of passive investments.

The ISIN of KIM ACE Global Big Pharma ETF Units is KR7497510008.

The total expense ratio of KIM ACE Global Big Pharma ETF Units is 0.30%, which means that investors pay 30.00 KRW per 10,000 KRW in investment capital annually.

The ETF is listed in KRW.

European investors may incur additional costs for currency exchange and transaction fees.

No, KIM ACE Global Big Pharma ETF Units does not comply with the EU UCITS investor protection directives.

The P/E ratio of KIM ACE Global Big Pharma ETF Units is 21.79.

KIM ACE Global Big Pharma ETF Units tracks the performance of the Solactive Global Big Pharma Index - Benchmark Price Return.

KIM ACE Global Big Pharma ETF Units is domiciled in KR.

The fund was launched on 11/19/2024.

The KIM ACE Global Big Pharma ETF Units mainly invests in Healthcare companies.

The NAV of KIM ACE Global Big Pharma ETF Units amounts to 12.86 B KRW.

The price-to-book ratio is 7.21.

Investments can be made through brokers or financial institutions that provide access to trading ETFs.

The ETF is traded on the stock exchange, similar to stocks.

Yes, the ETF can be held in a regular securities account.

The ETF is suitable for both short-term and long-term investment strategies, depending on the investor's goals.

The ETF is valued on a daily stock exchange basis.

Information on dividends should be requested from the provider's website or your broker.

The risks include market fluctuations, currency risks, and the risk associated with smaller companies.

The ETF is obligated to report regularly and transparently on its investments.

The performance can be viewed on Eulerpool or directly on the provider's website.

Further information can be found on the official website of the provider.